Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |